Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

AirSeal®Insufflation Trocar/CO2 Absorption Study

Not Applicable

Completed

Conditions: Gynecologic Diseases

Interventions: Device: Standard trocar
Device: AirSeal trocar

First Posted Date: 2016-01-13

Last Posted Date: 2021-09-16

Lead Sponsor: Columbia University

Target Recruit Count: 132

Registration Number: NCT02654808

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evaluation of FFR Measurements

Not Applicable

Completed

Conditions: Angina
Ischemia

Interventions: Device: St. Jude Medical Pressure Wire
Device: ACIST Navvus Microcatheter

First Posted Date: 2016-01-06

Last Posted Date: 2019-06-14

Lead Sponsor: Columbia University

Target Recruit Count: 74

Registration Number: NCT02648230

Locations: 🇺🇸
Columbia University, New York, New York, United States

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

Not Applicable

Completed

Conditions: Substance Use
AIDS
Hepatitis C
HIV

Interventions: Other: Control Group
Behavioral: Care Facilitation Group

First Posted Date: 2015-12-29

Last Posted Date: 2020-07-22

Lead Sponsor: Columbia University

Target Recruit Count: 422

Registration Number: NCT02641158

Locations: 🇺🇸
University Hospital at University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸
Grady Memorial Hospital / Ponce de Leon Center, Atlanta, Georgia, United States

and more 8 locations

Evaluation of Three Pulp Vitality Tests

Not yet recruiting

Conditions: Dental Pulp Vitality Testing
Dental Pulp Diseases

First Posted Date: 2015-12-21

Last Posted Date: 2024-05-02

Lead Sponsor: Columbia University

Target Recruit Count: 150

Registration Number: NCT02636504

ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer

Phase 1

Completed

Conditions: Metastatic Breast Cancer
Breast Carcinoma

Interventions: Drug: ACY-1215
Drug: Nab-paclitaxel

First Posted Date: 2015-12-16

Last Posted Date: 2021-01-07

Lead Sponsor: Columbia University

Target Recruit Count: 17

Registration Number: NCT02632071

Locations: 🇺🇸
Columbia Irving University Medical Center, New York, New York, United States

Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection

Early Phase 1

Withdrawn

Conditions: Breast Neoplasm
Carcinoma, Ductal, Breast
Carcinoma, Intraductal, Noninfiltrating

Interventions: Procedure: Iron-tracer guided axillary ultrasound and biopsy
Drug: Iron tracer

First Posted Date: 2015-11-20

Last Posted Date: 2019-03-26

Lead Sponsor: Columbia University

Registration Number: NCT02610920

Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

Recruiting

Conditions: Morbid Obesity
Childhood Obesity

Interventions: Diagnostic Test: Transcriptome profiling

First Posted Date: 2015-11-11

Last Posted Date: 2023-09-05

Lead Sponsor: Columbia University

Target Recruit Count: 12

Registration Number: NCT02602769

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
🇺🇸
Boston Children's Hospital, Boston, New York, United States

Propranolol Dose Escalation in Lymphedema in Patients

Phase 2

Terminated

Conditions: Primary Lymphedema

Interventions: Drug: Propranolol

First Posted Date: 2015-11-04

Last Posted Date: 2021-10-22

Lead Sponsor: Columbia University

Target Recruit Count: 1

Registration Number: NCT02595996

Locations: 🇺🇸
Columbia University, New York, New York, United States

MRI and PET to Assess Pembrolizumab Response

Early Phase 1

Terminated

Conditions: Malignant Melanoma, Metastatic

Interventions: Drug: Pembrolizumab
Drug: FLT PET

First Posted Date: 2015-10-29

Last Posted Date: 2022-12-30

Lead Sponsor: Columbia University

Target Recruit Count: 6

Registration Number: NCT02591654

Locations: 🇺🇸
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York, New York, United States

Tranexamic Acid Dosing for Total Joint Arthroplasty

Phase 4

Completed

Conditions: Arthropathy of Hip
Arthropathy of Knee

Interventions: Drug: Tranexamic Acid

First Posted Date: 2015-10-23

Last Posted Date: 2020-10-30

Lead Sponsor: Columbia University

Target Recruit Count: 84

Registration Number: NCT02584725

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy